Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
about
Cardiovascular side effects of atomoxetine and its interactions with inhibitors of the cytochrome p450 systemAssociations between psychiatric comorbidities and sleep disturbances in children with attention-deficit/hyperactivity disorder.Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderFunctional Connectivity of Child and Adolescent Attention Deficit Hyperactivity Disorder Patients: Correlation with IQ.Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.ADHD Symptoms and Quality of Life Across a 12-Month Period in Children With ADHD: A Longitudinal Study.Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Adults With ADHD.Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials.
P2860
Q33160256-21E85F88-08DA-46C8-81F3-52E1BE5CE085Q33834614-71351784-1D6F-4629-A4C8-F9269A17A238Q35183156-C474B187-CC2F-4A39-8CED-A22460C05F4AQ37199815-65A6BEB9-C4EE-4CB8-B22C-38EB9CAA90F6Q37402059-B4A8837C-C7FA-4E80-B238-4E1213C529A2Q37449726-1E456D08-86AF-4097-ACE6-CCDFC4A79051Q37603815-7AC423F3-169B-4F36-9B1E-C37295DD401EQ38362252-6A68C75D-51BE-4F6F-8E7C-13ACECD7FD5CQ38793964-FE89DD2C-1B31-46C9-A79C-6DAC721C0FD7Q38827483-1531734D-906A-4216-8ABD-1E85635F51C3Q39749601-FD62DB53-14F5-434F-8415-D33FF8123209Q48282755-B9C4FEE1-63E2-4B46-ADC2-463C75037D50Q48493146-CBDDFCC5-44CE-4249-B026-205226348E15
P2860
Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
type
label
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
prefLabel
Differences between children a ...... sis of five atomoxetine trials
@ast
Differences between children a ...... sis of five atomoxetine trials
@en
Differences between children a ...... sis of five atomoxetine trials
@nl
P2093
P2860
P921
P356
P1476
Differences between children a ...... sis of five atomoxetine trials
@en
P2093
Alexander Schacht
Nicola Savill
Peter M Wehmeier
Rodrigo Escobar
Val Harpin
P2860
P2888
P356
10.1186/1753-2000-4-30
P577
2010-12-06T00:00:00Z
P5875
P6179
1009790071